We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

126 hedge funds and large institutions have $1.26B invested in Rocket Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 44 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more call options, than puts

Call options by funds: $882K | Put options by funds: $98K

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

11% more capital invested

Capital invested by funds: $1.14B → $1.26B (+$123M)

6% more funds holding

Funds holding: 119 → 126 (+7)

1.77% more ownership

Funds ownership: 98.35% → 100.12% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

7% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 44

Holders
126
Holders Change
+7
Holders Change %
+5.88%
% of All Funds
2.54%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
20
Increased
41
Reduced
44
Closed
12
Calls
$882K
Puts
$98K
Net Calls
+$784K
Net Calls Change
-$499K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$23.4M
2
Goldman Sachs
Goldman Sachs
New York
+$11.4M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$6.28M
4
Deutsche Bank
Deutsche Bank
Germany
+$6.04M
5
Bank of America
Bank of America
North Carolina
+$5.5M

Top Sellers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
-$6.16M
2
TCM
Tekla Capital Management
Massachusetts
-$6.05M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$5.25M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.67M
5
Millennium Management
Millennium Management
New York
-$4.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
51
State of Wisconsin Investment Board
Wisconsin
$1.58M +$554K +22,500 +48%
Swiss National Bank
52
Swiss National Bank
Switzerland
$1.57M +$39.4K +1,600 +2%
CS
53
Credit Suisse
Switzerland
$1.57M +$741K +30,089 +78%
TD Asset Management
54
TD Asset Management
Ontario, Canada
$1.42M +$563K +22,858 +58%
Macquarie Group
55
Macquarie Group
Australia
$1.35M – – –
SF
56
Synovus Financial
Georgia
$1.29M +$119K +4,841 +9%
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$1.18M +$3.1K +126 +0.2%
Mirae Asset Global Investments
58
Mirae Asset Global Investments
South Korea
$1.12M +$390K +15,824 +48%
TIP
59
Torray Investment Partners
Maryland
$1.11M +$5.37K +218 +0.4%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$1.04M -$147K -5,950 -12%
William Blair & Company
61
William Blair & Company
Illinois
$892K +$5.45K +221 +0.6%
Rafferty Asset Management
62
Rafferty Asset Management
New York
$842K +$541K +21,975 +148%
Comerica Bank
63
Comerica Bank
Texas
$819K +$80.8K +3,280 +13%
UBS AM
64
UBS AM
Illinois
$811K +$101K +4,080 +13%
AllianceBernstein
65
AllianceBernstein
Tennessee
$800K -$34.5K -1,400 -4%
SMH
66
Sanders Morris Harris
Texas
$772K +$683K +27,709 New
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$764K – – –
Squarepoint
68
Squarepoint
New York
$752K -$612K -24,827 -43%
ECM
69
ExodusPoint Capital Management
New York
$676K +$729K +29,569 New
MPAM
70
Monarch Partners Asset Management
Massachusetts
$596K +$207K +8,410 +48%
SSA
71
Schonfeld Strategic Advisors
New York
$595K -$614K -24,934 -49%
HighTower Advisors
72
HighTower Advisors
Illinois
$518K +$19.7K +800 +4%
AG
73
Algert Global
California
$513K – – –
Wells Fargo
74
Wells Fargo
California
$474K -$301K -12,217 -37%
GCP
75
GSA Capital Partners
United Kingdom
$468K +$504K +20,466 New
1 2
3
4 5

RCKT Hedge Fund Activity: Q3 2020 in Review

126 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q3 2020, worth a combined $1.26B — up 11% from $1.14B a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new RCKT positions and 12 closed out — a net gain of 8 holders — while 41 added to existing stakes and 44 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $23.4M. The largest seller was Ghost Tree Capital, cutting an estimated $6.16M.

  • 126 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q3 2020, up from 119 in Q2 2020.
  • Funds reported $1.26B of Rocket Pharmaceuticals stock for Q3 2020, up 11% quarter-over-quarter.
  • 20 funds opened new Rocket Pharmaceuticals positions in Q3 2020 and 12 closed out, a net change of +8 holders.
  • The largest Rocket Pharmaceuticals buyer in Q3 2020 was T. Rowe Price Associates, an estimated $23.4M added.
  • The largest Rocket Pharmaceuticals seller in Q3 2020 was Ghost Tree Capital, an estimated $6.16M sold.

Based on aggregated 13F filings for Q3 2020.